World First for SHN

• Caring for your Physical & Emotional Wellbeing during the Pandemic
• Red4Research
• London Marathon boost for Little Bleeders
• World Haemophilia Day 2023
• Haemophilia Service Patient Survey 2023
• Haemophilia Society Reports Interim Payments
• Transformational Gene Therapy Research for Haemophilia B Patients
• Haemnet Podcast features SHN Team Members
• Update – Infected Blood Inquiry
• International Nurses Day 2020
• Infected Blood Inquiry Change of Dates
• World Haemophilia Day 2020
• Your Haemophilia Centre and Covid-19
• Fundraising for a Luminometer for NHH
• Hemlibra (Emicizumab) Approved for Treatment by NHS England
• Summer Travel Information
• Shaping the Network
• Infected Blood Inquiry
• Infected Blood Inquiry – Radio 5 Live
• Winning Information
• The End of the Fax
• Updated Ways to Contact Us – Basingstoke
• World First for SHN
• SHN at EAHAD
• Staff and patient engagement day
• New FAQ page
• New Clinical Director for the Network
• Christmas party and bowling fun!
• Panorama programme
• WFH2018 Congress

Dr Mangles, SHN’s Clinical Director and Hazel Cordial, Clinical Nurse Specialist at North Hampshire Hospital, Basingstoke attended the Bioverativ 242HA201 Investigator Meeting in Paris last weekend.

NHH, Basingstoke recruited the first global patient for the study and were invited to attend the meeting alongside study teams from across the world.